Natco Pharma Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Natco Pharma Company Profile :

Natco Pharma Limited is an Indian based holding pharmaceutical company engaged in the business of developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Company’s products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate.


Natco Pharma ResultsBSE Code : 524816
NSE Symbol : NATCOPHARM
ISIN No. : INE987B01026
Industry :   Pharmaceuticals
Face Value : Rs. 2.00


If you are an investor who has shares of Natco Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Natco Pharma.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Natco Pharma. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Natco Pharma.

Natco Pharma Q1 Results 2016-17 :

Natco Pharma will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Natco Pharma will announce its Q2 FY 2016-17 Results in the month of October 2016.

Natco Pharma will announce its Q3 FY 2016-17 Results in the month of January 2017.

Natco Pharma will announce its Q4 FY 2016-17 Results in the month of April 2017.

Natco Pharma will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Natco Pharma Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 1021.43 1141.62
Other Income  14.07  10.76
Total Income  1035.50  1152.38
Expenditure  -743.93  -922.84
Interest  -21.94  -22.90
Depreciation  -50.16  -50.95
PBT  219.47  206.64
Tax  -45.01  -52.80
Net Profit  174.46  153.84
Equity  34.83  34.83
EPS  10.24  9.10

Note : If you like this information about Natco Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.